Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 26.88
+0.68 (2.60%)
Oct 23, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 10.9 billion as of October 22, 2026. It is the 7,774th most valuable company in the world and the 1,503rd biggest in China. Its market cap has increased by 15.91% in one year.
Market Cap
10.90B
Enterprise Value
11.19B
Revenue
759.63M
Global Rank
Country Rank
#1,503 China
PE Ratio
n/a
ChartMarket Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 10.90B, a decrease of -32.61%. That is a compound annual growth rate of -7.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 10.90B | 5.86% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 12.64B |
| GemPharmatech | 11.37B |
| Nanjing Vazyme Biotech | 10.90B |
| Hualan Biological Vaccine | 10.83B |
| Tibet Cheezheng Tibetan Medicine | 10.78B |
| Shanghai Medicilon | 10.25B |
| Inner Mongolia Furui Medical Science | 10.16B |
| Chengzhi | 9.56B |